The Medical Wig Starts With the Scalp

Why Foundation Design Must Begin With Living Tissue

Hair & Wig Science Series | HIASTI

This article introduces the clinical framework examined in The Science of Wig Foundations: A Clinical Guide to Scalp Health, Volume One of the Hair and Wig Science Series.

A cranial prosthesis is not made for a head. It is made for a scalp, and the difference between those two statements is the difference between a unit that serves a patient for years and one that has to be abandoned in six weeks.

We build for living tissue. That tissue has its own chemistry, its own microbial balance, its own repair capacity, and in medically compromised patients, its own injuries. Every decision in the build sequence, from base material to ventilation density to securing method, is a decision about how that tissue will be treated for twelve hours a day.

This is where the work begins.

The scalp is not ordinary skin

The scalp carries the highest concentration of sebaceous glands on the body, alongside the face, at densities reported up to 400 to 900 glands per square centimeter. It holds roughly 100,000 hair follicles, each one a channel through the epidermis. Its surface sits at a pH of about 4.5 to 5.5, and that acidity is not incidental. It suppresses bacterial and fungal overgrowth and supports the free fatty acid chemistry that keeps the barrier intact.

Two structures do the protective work. The stratum corneum, the outermost layer of dead keratinized cells, functions as the primary barrier against water loss and against entry by irritants and organisms. The sebaceous glands supply sebum, a lipid mixture of triglycerides, fatty acids, wax esters, and squalene that lubricates the surface and carries antimicrobial properties of its own.

Barrier integrity is measured clinically as transepidermal water loss, the rate at which water evaporates through the skin. Values vary by anatomical site and rise when the barrier is disturbed, which makes the measurement a sensitive early indicator of irritation.

None of this is academic. A scalp with an intact acid mantle, functioning sebum production, and an unbroken stratum corneum can tolerate a great deal. A scalp that has lost any one of those defenses cannot.

What illness does before a unit is ever fitted

Most of our patients do not arrive with healthy scalps.

In chemotherapy-induced alopecia, scalp discomfort is close to universal. In one study of breast cancer patients undergoing chemotherapy, every patient who completed the questionnaire reported unpleasant scalp sensations, with the large majority describing both itching and trichodynia, the clinical term for scalp pain, and the remainder describing pain alone. The sensations tracked the onset and duration of hair loss.

This matters for design in a specific way. A scalp registering pain in the absence of any external stimulus will register far more from a base seam, an adhesive edge, or an elastic band that a healthy scalp would never notice.

Alopecia areata brings perifollicular inflammation. Scarring alopecias bring fibrosis and permanent follicular loss. Radiation brings thinned, fragile tissue with reduced healing capacity. Autoimmune and immunosuppressive treatment reduces the scalp's ability to clear a minor infection that would otherwise resolve without notice.

The scalp we are building for is frequently a scalp already under load. Adding to that load is a clinical decision, not a styling one.

Occlusion changes the environment we are building into

Any prosthesis covers the scalp, and covering skin changes it.

Normal stratum corneum water content sits between roughly 10 and 30 percent. Above roughly 35 percent, the barrier itself can be harmed. Excess hydration swells the keratinocytes, opens channels between them, and makes the tissue more permeable and less resistant to mechanical force.

Prolonged occlusion does more than raise water content. It alters epidermal lipids, epidermal turnover, surface pH, and the resident microbial population. It also increases percutaneous absorption of lipid-soluble compounds, which means that anything sitting against an occluded scalp penetrates more readily than the same substance would on open skin.

Read those two findings together and the clinical picture is clear. An occlusive base does not simply cover the scalp. It can raise hydration, alter surface pH, change the resident microbial environment, and increase the absorption of whatever adhesive or solvent is held against the skin. How far those effects go depends on the material, the wear time, the ambient heat, and the condition of the individual scalp. That is the mechanism by which a well-made unit can still cause a reaction.

This is why base selection is a medical decision. Breathability, panel placement, and the ratio of open to closed structure determine the microclimate the patient lives in.

Adhesives are a chemical exposure

Hair prosthesis adhesives and tapes vary widely in chemistry. Depending on the product they may contain acrylates, methacrylates, cyanoacrylate compounds, resins, solvents, and other potential irritants or sensitizers. One fixative composition documented in the dermatological literature runs approximately 90.6 percent ethyl cyanoacrylate, 9.0 percent polymethyl methacrylate, 0.4 percent hydroquinone, and trace organic sulfonic acid. That is a documented example rather than a description of every product on the market.

Cyanoacrylates were long assumed to be low-risk sensitizers because they polymerize almost instantly, limiting the time available to bind with skin proteins. The case literature has revised that assumption. Allergic contact dermatitis has been documented from hair prosthesis fixatives, from wig-fixing adhesive tape, and from adhesive applied along the anterior hairline, with patch testing confirming reactions to specific acrylate monomers. In one series of 275 patients, 17.5 percent reacted to at least one acrylate or methacrylate.

The consequences are not always minor. Erosive pustular dermatosis of the scalp, a difficult inflammatory condition, has been reported following contact dermatitis from a prosthetic hairpiece.

Two design conclusions follow. First, adhesive-free securing methods are not a lesser option, they are the appropriate default for compromised, immunosuppressed, or previously sensitized scalps. Second, when adhesive is genuinely indicated, the patient deserves a compatibility check before full application rather than after a reaction.

Tension is the injury we cause ourselves

Traction alopecia affects up to one third of women of African descent who wear high-tension styles over time. It presents as marginal hair loss along the frontal, temporal, and occipital hairline, often with a retained fringe of fine miniaturized hairs, the sign clinicians use to distinguish it from frontal fibrosing alopecia.

Early traction alopecia is reversible when the tension stops. Continued traction progresses to scarring, and scarred follicles do not return. Trichoscopic documentation exists of marginal hair loss following removal of a glued wig, and density measurements in marginal traction alopecia show dramatic reductions against unaffected sites on the same scalp.

The instruments of that damage are familiar to every practitioner: braided foundations under a unit, internal combs biting into the hairline, elastic bands worn tight enough to hold a unit through a workday, and clips anchored repeatedly into the same few follicles.

A prosthesis prescribed to address hair loss should not be the cause of further hair loss. That is not a matter of preference. It is the standard.

What this means for the build

Every element of the HIASTI build sequence, twenty-two phases and more than sixty steps from consultation through final fitting, traces back to scalp findings.

The consultation establishes the scalp's actual condition, not the patient's diagnosis alone. Sebum production, sensitivity, inflammation, existing traction damage, prior reactions, and treatment schedule all inform what follows.

The mold captures the scalp as it is now, which is why compromised patients often need a fresh mold rather than a prior one, and why an accurate mold reduces the tension needed to hold the unit.

Base selection balances undetectability against breathability. The most invisible base is not automatically the correct one. For sensitive or immune-compromised patients, that trade favors the scalp.

Ventilation density affects weight, heat retention, and airflow at the surface. Density is a clinical variable, not only a cosmetic one.

The securing method is chosen from the scalp's tolerance for adhesive and tension, not from convenience or from what the practitioner is most used to fitting.

Follow-up exists because scalps change. A unit appropriate during active treatment may be wrong six months later when hair returns or when the barrier recovers.

The standard

A medical wig that ignores the scalp is a cosmetic object with a clinical label attached. The materials may be excellent and the ventilation flawless, and the unit will still fail the patient if it macerates the skin, sensitizes it, or pulls on what follicles remain.

We build the other way around. The scalp is assessed first, and the unit is designed to protect it. Everything else, including how beautiful the result is, follows from that decision rather than competing with it.

Where the work goes next

The scalp is where medical wig planning begins. The foundation is where those clinical decisions become physical.

Material, permeability, weight, edge design, ventilation pattern, and securing method are the levers that determine how a prosthesis behaves against living tissue across a full day of wear. Each one can be specified well or specified badly, and the scalp registers the difference.

That is the subject of The Science of Wig Foundations: A Clinical Guide to Scalp Health, Volume One of the Hair and Wig Science Series, where we examine how construction decisions affect comfort, barrier function, heat, moisture, tension, chemical exposure, and long-term scalp tolerance.

© 2026 Hairline Illusions™ | HIASTI | Hair & Wig Science Series. All rights reserved. This article is for professional education and is not a substitute for individualized medical evaluation. No portion of this publication may be reproduced, distributed, transmitted, or excerpted in any form or by any means, including digital, print, or screenshot, without prior written permission from Hairline Illusions LLC.